Coronavirus
- Rapid method of isothermal nucleic acid amplification that does not require thermal cycler
- Easy-to-use format, just thaw Master Mix before use (see Package Insert)
- Eliminates the need for dedicated molecular space and costly capital equipment, allowing for testing in smaller labs
- Requires minimal training
The Solana SARS-CoV-2 Assay is an isothermal Reverse Transcriptase - Helicase-Dependent Amplification (RT-HDA) assay intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal (NP) and nasal (NS) swab specimens from individuals suspected of COVID-19 by their healthcare provider. Molecular identification of SARS-CoV-2 occurs by the use of targeting highly conserved regions of the SARS-CoV-2 virus non-structural Polyprotein (pp1ab). The assay consists of two major steps: (1) specimen preparation, and (2) amplification and detection of target sequences specific to SARS-CoV-2 using isothermal Reverse Transcriptase — Helicase-Dependent Amplification (RT-HDA) in the presence of target-specific fluorescence probes which is performed in the Solana instrument. Results are displayed on the touchscreen, can be saved to the instrument, printed, and are capable of being sent to the LIS and exported through one of Solana’s five USB ports. Solana SARS-CoV-2 Assay is also supported by the power of Virena®.
» Rapid method of isothermal nucleic acid amplification that does not require thermal cycler
» Easy-to-use format, just thaw Master Mix before use (see Package Insert)
» Eliminates the need for dedicated molecular space and costly capital equipment, allowing for testing in smaller labs
» Requires minimal training
| Item Number | QUIM313 |
| Packaging | 96 Tests/BX |
